SAN FRANCISCO, August 06, 2025--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the enrollment of the first participant in ECLIPSE 3. All three trials in the Company’s registrational ...

All three trials in the Company’s registrational ECLIPSE program for chronic hepatitis delta (CHD) have now been initiated.

ECLIPSE is a registrational program to evaluate the safety and efficacy of tobevibart in combination with elebsiran in patients with chronic hepatitis delta (CHD).

Florida Governor Ron DeSantis shared some sharp criticism of the H-1B visa program, even as Trump maintains legal immigration levels.

Harvesters Kansas City reducing 9% of feeding programs after COVID-19 funds run out The API failed to deliver the resource.

Analyst David Pollack pinpoints which college football team has the best running back room in the nation.

The redshirt freshman rusher was no longer on the roster during the start of fall camp. BYU offensive coordinator Aaron Roderick confirmed to the media he would not be with the program this year ...

Action News Jax’s Ben Becker has learned that the company now operating the Jacksonville Housing Authority’s Housing Choice Voucher Program is under federal scrutiny.

World, Americas Israel's aid distribution program being run like the Hunger Games, says whistleblower 'This isn't something that happened just once or twice.

As pandemic-era federal emergency rental assistance comes to an end, Columbus City Council is setting up its own solution.